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There is increasing evidence that many HIV exposed,
seronegative individuals generate HIV-specific cellular
immune responses. IFNg ELISPOT has emerged as one of
the widely used assay to monitor HIV-specific immune
responses. It is becoming the assay of choice for evalua-
tion of HIV-vaccine-induced cell-mediated immune
responses in many clinical trials. However, HIV specific
IFNg T cell responses often wane with time and may even-
tually become undetectable using the direct ELISpot
method. There is need for a more sensitive detection
method to enhance the detection of such responses when
they fall below levels detectable by direct ELISpot. This
study seeks to determine if cultured ELISpot enhance
detection of low HIV specific immune responses. 12 high-
risk HIV negative individuals were followed up every 3
months for 9 months. During follow-up history was
obtained, HIV rapid tests performed and blood samples
obtained for assessment of HIV specific responses using
both direct and cultured ELISpot assays. 5 discordant cou-
ples were also recruited and HIV specific responses
assessed by both direct and cultured ELISpot. Preliminary
data shows that there were no IFNg responses detected by
direct ELISpot. 6/12 high-risk HIV seronegative volunteers
gave positive responses to 1, 2, 4, 9 and 90 peptide pools
using Cultured ELISpot at different time points during fol-
low up. Positive responses range from 125 to 1934 spot
forming units (SPU/106).
The results indicate that cultured ELISpot amplified the
immune responses and thus enhanced their detection. It
appears that cultured ELISpot is more sensitive than direct
Elispot and it is the test of the future.
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